-
Eligo Bioscience Awarded $5 Million To Advance Breakthrough Genetic Medicine Platform For Immuno-Dermatology
13 May 2025 10:05 GMT
… in Nature , securing multiple foundational patents covering in situ editing of … enables to perform in-situ genetic engineering of these commensal bacteria …
-
Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate
12 May 2025 08:00 GMT
… STS)
Thermosome adds 4 patents to its growing patent … most important market for patent-protected drugs. In parallel … applications recently published. These patents strengthen the protection of … of small molecules and genetic material.
These patent applications …
-
Revolutionizing Retinal Therapy: The Role of Nanoparticle Drug Carriers in Managing Vascular Retinal Disorders
15 May 2025 08:29 GMT
… for the purpose of delivering genetic material. However, due to the … polymer nanoparticles for delivery of genetic drugs. Nature Rev Mater. 2023 … Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer …
-
Artificial Intelligence And Genetics Can Help Farmers Grow Corn With Less Fertilizer
15 May 2025 06:57 GMT
Novel process harnesses machine learning to reveal groups of genes that determine how efficiently plants use nitrogen
New York University scientists are using artificial intelligence to determine which genes collectively govern nitrogen use efficiency in …
-
Revolutionizing Agriculture: How AI and Genetics Enable Farmers to Cultivate Corn with Reduced Fertilizer Use
15 May 2025 00:39 GMT
In a groundbreaking advancement at New York University, scientists are pioneering a novel methodology utilizing artificial intelligence (AI) to unravel the complex genetic network that influences nitrogen use efficiency (NUE) in crops, particularly corn. …
-
GLP-1 Medication Is Changing The Ways Dallasites Lose Weight
14 May 2025 23:16 GMT
… neoplasia Type 2 (MEN2), a genetic disorder that causes susceptibility to … and Bariatrics specializes in the patented Mini Sleeve, a minimally invasive …
-
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)
14 May 2025 21:34 GMT
… can be caused by certain genetic syndromes or mutations. The … can be caused by certain genetic syndromes or mutations. It … advances, new products and patents attained by competitors; challenges inherent … of the company’s patents and other protections for …
-
Viruses that roam the fungal kindgom
14 May 2025 21:22 GMT
… the American fungi were of genetic types unable to accept transfer … ’t yet hit the market, patents are approved in China, Canada …
-
Quoin Announces Positive QRX003 Data for Pediatric Peeling Skin Syndrome
14 May 2025 19:40 GMT
… regulatory approval for another rare genetic disease. We are also continuing … ;Quoin-Pharmaceuticals-Files-U-S-Patent-Application-for-Novel-Topical-Formulations …
-
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
14 May 2025 17:03 GMT
… pre-processing. It uses a patented process to enable optimization of … on unwanted toxicities in specific genetic backgrounds.
Unlike black-box approaches … addressing patient populations with rare genetic mutations.
With a strong foundation …